Literature DB >> 20097675

Molecular and functional effects of organismal ageing on smooth muscle cells derived from bone marrow mesenchymal stem cells.

Juhee Han1, Jin Yu Liu, Daniel D Swartz, Stelios T Andreadis.   

Abstract

AIMS: Bone marrow-derived smooth muscle cells (BM-SMCs) have high potential as an autologous cell source of vascular progenitors but normal cell function and turnover frequency may decline with age. In this study we set out to study the effects of organismal ageing on the molecular and functional properties of BM-SMCs. METHODS AND
RESULTS: To address this issue, we employed a smooth muscle alpha-actin promoter (alphaSMA) driving expression of enhanced green fluorescence protein (EGFP) to isolate SMCs from bone marrow of neonatal (nBM-SMCs) or adult (aBM-SMCs) sheep and examined their proliferation potential and contractility. Compared with nBM-SMCs, aBM-SMCs exhibited lower clonogenicity and proliferation potential that could be improved significantly by addition of basic fibroblast growth factor. Vascular constructs from aBM-SMCs showed reduced ability to generate force and contract fibrin hydrogels and this function could be partially restored by addition of transforming growth factor-beta1. They also exhibited lower receptor- and non-receptor-mediated vascular contractility and mechanical strength, which was comparable to that of tissue constructs prepared with vascular SMCs from neonatal umbilical veins. In agreement with the contractile properties and mechanical strength of vascular constructs, aBM-SMCs displayed significantly lower expression of alphaSMA, smoothelin, desmin, type I collagen, and tropoelastin transcripts compared with nBM-SMCs.
CONCLUSION: Understanding the effects of organismal ageing on BM-SMCs and the properties of the resulting vascular constructs may lead to innovative ways to facilitate application of these cells in the treatment of cardiovascular disease which is especially prevalent in the elderly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097675      PMCID: PMC2883893          DOI: 10.1093/cvr/cvq024

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  47 in total

1.  Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells.

Authors:  Zhi-Yong Zhang; Swee-Hin Teoh; Mark S K Chong; Jan Thorsten Schantz; Nicholas M Fisk; Mahesh A Choolani; Jerry Chan
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

2.  Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells.

Authors:  M Mastrogiacomo; R Cancedda; R Quarto
Journal:  Osteoarthritis Cartilage       Date:  2001       Impact factor: 6.576

3.  Alpha-smooth muscle actin expression upregulates fibroblast contractile activity.

Authors:  B Hinz; G Celetta; J J Tomasek; G Gabbiani; C Chaponnier
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

4.  Age-related loss of proliferative activity of human vascular smooth muscle cells in culture.

Authors:  A Ruiz-Torres; A Gimeno; J Melón; L Mendez; F J Muñoz; M Macía
Journal:  Mech Ageing Dev       Date:  1999-10-01       Impact factor: 5.432

5.  Selective microvascular dysfunction in mice lacking the gene encoding for desmin.

Authors:  Laurent Loufrani; Khalid Matrougui; Zhenlin Li; Bernard I Levy; Patrick Lacolley; Denise Paulin; Daniel Henrion
Journal:  FASEB J       Date:  2001-11-29       Impact factor: 5.191

6.  Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries.

Authors:  Harald Bär; P Wende; L Watson; S Denger; G van Eys; J Kreuzer; L Jahn
Journal:  Basic Res Cardiol       Date:  2002-01       Impact factor: 17.165

7.  Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF.

Authors:  S Tsutsumi; A Shimazu; K Miyazaki; H Pan; C Koike; E Yoshida; K Takagishi; Y Kato
Journal:  Biochem Biophys Res Commun       Date:  2001-10-26       Impact factor: 3.575

8.  Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells.

Authors:  B Kinner; J M Zaleskas; M Spector
Journal:  Exp Cell Res       Date:  2002-08-01       Impact factor: 3.905

9.  Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs).

Authors:  Zhaodi Gong; Laura E Niklason
Journal:  FASEB J       Date:  2008-01-16       Impact factor: 5.191

10.  Contractile smooth muscle cells derived from hair-follicle stem cells.

Authors:  Jin Yu Liu; Hao Fan Peng; Stelios T Andreadis
Journal:  Cardiovasc Res       Date:  2008-03-03       Impact factor: 10.787

View more
  24 in total

Review 1.  Smooth muscle and other cell sources for human blood vessel engineering.

Authors:  Sumati Sundaram; Laura E Niklason
Journal:  Cells Tissues Organs       Date:  2011-10-25       Impact factor: 2.481

Review 2.  Stem cell sources for vascular tissue engineering and regeneration.

Authors:  Vivek K Bajpai; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2012-07-03       Impact factor: 6.389

3.  Differential effects of culture senescence and mechanical stimulation on the proliferation and leiomyogenic differentiation of MSC from different sources: implications for engineering vascular grafts.

Authors:  Maxwell T Koobatian; Mao-Shih Liang; Daniel D Swartz; Stelios T Andreadis
Journal:  Tissue Eng Part A       Date:  2015-03-03       Impact factor: 3.845

4.  NANOG Restores Contractility of Mesenchymal Stem Cell-Based Senescent Microtissues.

Authors:  Aref Shahini; Panagiotis Mistriotis; Mohammadnabi Asmani; Ruogang Zhao; Stelios T Andreadis
Journal:  Tissue Eng Part A       Date:  2017-02-28       Impact factor: 3.845

5.  Cellular Self-Assembly with Microsphere Incorporation for Growth Factor Delivery Within Engineered Vascular Tissue Rings.

Authors:  Hannah A Strobel; Anna D Dikina; Karen Levi; Loran D Solorio; Eben Alsberg; Marsha W Rolle
Journal:  Tissue Eng Part A       Date:  2016-12-06       Impact factor: 3.845

6.  Hair follicle: a novel source of multipotent stem cells for tissue engineering and regenerative medicine.

Authors:  Panagiotis Mistriotis; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-03       Impact factor: 6.389

7.  Magnetofection Mediated Transient NANOG Overexpression Enhances Proliferation and Myogenic Differentiation of Human Hair Follicle Derived Mesenchymal Stem Cells.

Authors:  Seoyoung Son; Mao-Shih Liang; Pedro Lei; Xiaozheng Xue; Edward P Furlani; Stelios T Andreadis
Journal:  Bioconjug Chem       Date:  2015-03-10       Impact factor: 4.774

8.  Engineering fibrin-binding TGF-β1 for sustained signaling and contractile function of MSC based vascular constructs.

Authors:  Mao-Shih Liang; Stelios T Andreadis
Journal:  Biomaterials       Date:  2011-08-23       Impact factor: 12.479

9.  Surgical technique for the implantation of tissue engineered vascular grafts and subsequent in vivo monitoring.

Authors:  Maxwell T Koobatian; Carmon Koenigsknecht; Sindhu Row; Stelios Andreadis; Daniel Swartz
Journal:  J Vis Exp       Date:  2015-04-03       Impact factor: 1.355

10.  Cadherin-11 regulates both mesenchymal stem cell differentiation into smooth muscle cells and the development of contractile function in vivo.

Authors:  Stella Alimperti; Hui You; Teresa George; Sandeep K Agarwal; Stelios T Andreadis
Journal:  J Cell Sci       Date:  2014-04-16       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.